FIGS logo

FIGS INC-CLASS A

FIGSNYSE
πŸ† #1538 by market capEarnings Nov 5US Equity
$542.22β–² $30.53 (+5.63%)
Simulated price
1hβ€”
24hβ–² 5.6%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$2.37B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+24.7%
Healthy
πŸ“ŠGross Margin
68.9%
High
πŸ’΅FCF Margin
14.5%
Healthy
βš–οΈP/S Ratio
3.4x
Fair
Otter Score
62
Fair
No chart data available for FIGS.

Trading Snapshot

Day Range
$534.53 – $544.76
52-Week Range
$6.07 – $17.48
Volume
$2.64B
Avg Volume
$3.10B
Shares Outstanding
167.1M
Next Earnings
Oct 9, 2026

Fundamentals Snapshot

Annual Revenue
$631M
Last Q Revenue
$197M
P/E Ratio
38.6
P/S Ratio
3.4x
EPS (TTM)
$0.32
Dividend Yield
β€”

Why Investors Own FIGS

  • βœ“High-growth profile β€” revenue up +22.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 80% gross margin and 23% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$631Mβ–² +17.0% YoY
Gross Margin (TTM)
79.8%β–² +2.1% YoY
Operating Income (TTM)
$157Mβ–² +17.0% YoY
Free Cash Flow (TTM)
$148Mβ–² +17.0% YoY

About FIGS INC-CLASS A

FIGS, Inc. functions as a direct-to-consumer enterprise specializing in healthcare apparel and lifestyle merchandise across the United States. The company innovates and distributes a comprehensive selection of medical uniforms, complemented by a diverse array of non-scrub items. These offerings span functional pieces like lab coats, under-scrubs, compression socks, footwear, and masks, extending to activewear, loungewear, and outerwear such as performance leggings, sports bras, various tops (including super-soft pima cotton options), vests, and jackets. Customers can access and purchase FIGS' products directly through its integrated digital platform, which encompasses both its official website and mobile application. Founded in 2013, FIGS, Inc. is headquartered in Santa Monica, California.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
62/100

Analyst Price Target

β“˜
Average Target
$715.03
β–² +31.9% Upside
High Target$863.95
Low Target$657.23
Based on 37 analysts

Latest News & Updates